Published in Nat Microbiol on September 05, 2016
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
XDS. Acta Crystallogr D Biol Crystallogr (2010) 67.46
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
Development and testing of a general amber force field. J Comput Chem (2004) 23.29
The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature (2007) 11.73
Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26
Shape complementarity at protein/protein interfaces. J Mol Biol (1993) 10.40
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature (2011) 7.20
Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science (1992) 4.74
Complement evasion by human pathogens. Nat Rev Microbiol (2008) 4.24
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. J Chem Theory Comput (2011) 3.98
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput (2013) 3.64
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis (2009) 3.51
The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell (1992) 3.27
Locally accessible conformations of proteins: multiple molecular dynamics simulations of crambin. Protein Sci (1998) 2.94
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. J Chem Theory Comput (2011) 2.35
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine (2011) 1.98
Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol (2006) 1.92
A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J Infect Dis (2014) 1.85
Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol (2009) 1.73
Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science (2008) 1.70
Production of selenomethionyl proteins in prokaryotic and eukaryotic expression systems. Methods Mol Biol (2007) 1.45
High-performance scalable molecular dynamics simulations of a polarizable force field based on classical Drude oscillators in NAMD. J Phys Chem Lett (2011) 1.41
Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med (2003) 1.33
Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect (2013) 1.18
Rational Design of Particle Mesh Ewald Compatible Lennard-Jones Parameters for +2 Metal Cations in Explicit Solvent. J Chem Theory Comput (2013) 1.16
Group A streptococcal vaccines: paving a path for accelerated development. Vaccine (2013) 1.12
Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes. Mol Microbiol (2001) 1.09
Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. J Immunol (2000) 1.08
Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry (2006) 1.06
Fast Analysis of Molecular Dynamics Trajectories with Graphics Processing Units-Radial Distribution Function Histogramming. J Comput Phys (2011) 1.02
Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis. Biochem J (1986) 1.01
Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J Immunol (1996) 0.96
Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor. J Biol Chem (2005) 0.96
Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog (2006) 0.96
The nonideal coiled coil of M protein and its multifarious functions in pathogenesis. Adv Exp Med Biol (2011) 0.96
The Hypervariable region of Streptococcus pyogenes M protein escapes antibody attack by antigenic variation and weak immunogenicity. Cell Host Microbe (2011) 0.95
Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence. PLoS Pathog (2013) 0.90
Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells. J Biol Chem (2013) 0.82
Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors. PLoS Pathog (2015) 0.81
The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice. J Infect Dis (2010) 0.79
C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend. Immunol Lett (2015) 0.78
Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci. Expert Rev Vaccines (2015) 0.76